The effect of fluticasone, budesonide and mometasone on nasal polyposis
Phase 3
Recruiting
- Conditions
- asal polyps.Nasal polyp
- Registration Number
- IRCT20190618043934N7
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Patients with chronic rhinosinusitis with nasal polyps who have undergone sinus endoscopic surgery.
Patients aged 15 to 70 years
Having conscious satisfaction
Exclusion Criteria
Existence of eye disease
Existence of known immunodeficiency disease
Infectious symptoms include purulent discharge from the back of the throat and nose
Having Allergic rhinitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Runny nose. Timepoint: runny nose before and After treatment. Method of measurement: By asking the patient.;Headache. Timepoint: headache before and After treatment. Method of measurement: By asking the patient.;Nasal congestion before and After treatment. Timepoint: nasal congestion. Method of measurement: By asking the patient.;Sinus pain. Timepoint: sinus pain before and After treatment. Method of measurement: By asking the patient.;Pain around the eyes. Timepoint: pain around the eyes before and After treatment. Method of measurement: By asking the patient.;Pus in the nose. Timepoint: pus in the nose before and After treatment. Method of measurement: By asking the patient.;Cough. Timepoint: cough before and After treatment. Method of measurement: By asking the patient.;Decreased sense of smell Before and After Treatment. Timepoint: Decreased sense of Smell Before and After Treatment. Method of measurement: By Asking The Patient.
- Secondary Outcome Measures
Name Time Method